Roberto Tozzi1, Jvan Casarin2, Ahmet Baysal3, Ciro Pinelli2, Luka Matak4, Nahid Ghanbarzadeh5, Moiad Alazzam3, Riccardo Garruto-Campanile3, Hooman Soleymani Majd3, Yakup Kilic3, Matteo Morotti3. 1. Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK. Electronic address: roberto.tozzi@wrh.ox.ac.uk. 2. Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK; Department of Obstetrics and Gynecology, University of Insubria, Varese, Italy. 3. Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK. 4. Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK; Department of Obstetrics and Gynaecology, General Hospital Zadar, Croatia. 5. Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK; Department of Obstetrics and Gynaecology, Birjand University of Medical Sciences, Iran.
Abstract
OBJECTIVES: To assess the impact of multiple bowel resections on postoperative outcomes in stage IIIC-IV ovarian cancer (OC). METHODS: From the Oxford OC database we retrieved consecutive patients who underwent bowel resection between January 2009 and November 2017. Patients were divided into two groups: single bowel resection (SBR) and MBR (≥2 bowel resections). The following outcomes were compared between the two groups: 30-day related and not related morbidity to bowel surgery, bowel diversion rate and time to start/restart adjuvant chemotherapy. RESULTS: Thirty-five patients were in the MBR and 146 in the SBR group. The 30-day overall surgical-related complication and bowel specific complications rate was higher in MBR group than SBR group (54.3% vs. 23.9%, p < 0.001) and (25.7% vs. 10.5%, p = 0.035), respectively. The rate of bowel diversion was 97.7% in MBR vs. 26.7% in the SBR group (p = 0.021). Trend analysis showed a significant reduction in the rate of MBR after the introduction of NACT (p- for trend <0.001). CONCLUSIONS: Our data show that MBR during OC surgery is associated with a higher rate of overall and bowel specific complication compared to SBR. The introduction of NACT is associated with a reduced rate of MBR.
OBJECTIVES: To assess the impact of multiple bowel resections on postoperative outcomes in stage IIIC-IV ovarian cancer (OC). METHODS: From the Oxford OC database we retrieved consecutive patients who underwent bowel resection between January 2009 and November 2017. Patients were divided into two groups: single bowel resection (SBR) and MBR (≥2 bowel resections). The following outcomes were compared between the two groups: 30-day related and not related morbidity to bowel surgery, bowel diversion rate and time to start/restart adjuvant chemotherapy. RESULTS: Thirty-five patients were in the MBR and 146 in the SBR group. The 30-day overall surgical-related complication and bowel specific complications rate was higher in MBR group than SBR group (54.3% vs. 23.9%, p < 0.001) and (25.7% vs. 10.5%, p = 0.035), respectively. The rate of bowel diversion was 97.7% in MBR vs. 26.7% in the SBR group (p = 0.021). Trend analysis showed a significant reduction in the rate of MBR after the introduction of NACT (p- for trend <0.001). CONCLUSIONS: Our data show that MBR during OC surgery is associated with a higher rate of overall and bowel specific complication compared to SBR. The introduction of NACT is associated with a reduced rate of MBR.
Authors: Carlos A Munoz-Zuluaga; Armando Sardi; Michelle Sittig; Vadim Gushchin; Mary C King; Carol Nieroda; Felipe Lopez-Ramirez; Teresa P Diaz-Montes Journal: Int J Surg Oncol Date: 2020-12-16